Work

Intravitreal Anti-vascular Endothelial Growth Factor Therapy With Pegaptanib for Advanced Von Hippel-lindau Disease of the Retina

Year: 2007

Type: article

Study design: Clinical Trial

Source: Retina

DOI: 10.1097/iae.0b013e318030a290

Authors: SAM S. DAHR, MICHAEL CUSICK, HANNA RODRIGUEZ-COLEMAN, SUNIL K. SRIVASTAVA, DARBY J. THOMPSON, W MARSTON LINEHAN, FREDERICK L. FERRIS, EMILY Y. CHEW

Institutions: National Institutes of Health, National Eye Institute, Emmes (United States), National Cancer Institute

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Eye Institute

Awards: G424296001, Medical Retina Fellowship

OpenAlex ID: W2017395282

FWCI: 5.38

Cites: 30

Cited by: 81

Related to: 10